MMPI is delighted to announce the launch of its new investment product – the MMPI Escalator Plan Series 62. The investment is underpinned by the French bank BNP Paribas – a highly-regarded international bank with a stable credit rating of A+.
The MMPI Escalator Plan Series 62 offers a great opportunity to invest in the stock markets with additional capital protection that is not normally available to investors. There is conditional capital security, which means that BNP will underwrite 100% of the investment unless the markets fall by 40% or more. This is not a traditional deposit account and the investment is not suitable for any investor who believes that it will behave like a traditional deposit account. It has an innovative design that allows it to offer a far greater potential return than a deposit account. But this reward is off-set by the risk that investors may not get back all of the money invested.
This risk/reward balance is a well-worn topic of debate amongst investors. All investments carry a certain level of risk – it would be foolish to think otherwise. Some investors naively believe that there’s no risk in investing money in a bank. But banks can go bust! On its 7-point risk scale MMPI always demonstrates this risk by scoring bank deposits as a 2. The jargon used to describe this threat is counterparty risk – in other words, the risk that the investor’s counterparty bank may default on its commitments (for whatever reason).
In comparison, Series 62 scores 4 on the 7-point risk scale. This is two notches higher up the curve, which is a clear enough signal of the additional prospective risk being undertaken in return for a potentially higher reward.
Series 62 is an investment that’s dependent on the performance of the EuroStoxx Select Dividend 30 index. The product has two versions. It will pay a potential compound annual rate of 4.40% (Option 62A) or 7.90% (Option 62B) after 12 months if the index outperforms.
Series 62 is designed to terminate once there is a pay-out or, alternatively, to rollover for a further 6 months at an increased potential return if there is no pay-out. Series 62 will not suit everybody but it is easy to understand and it is presented in fair and transparent language. The transparency allows investors to examine under the bonnet and to make a balanced judgement on the investment opportunity presented.
Prior to considering an investment in the MMPI Escalator Plan Series 62 please read the product brochure, including the appropriate WARNINGS that highlight the investment risks. Series 62 also has a key information document, specifically designed for potential investors, that is written in a standardised format allowing investors to compare Series 62 seamlessly against other investment products.
Should you require further details about any aspect of the MMPI Escalator suite of investment products please call MMPI on (01) 66 88 322 or e-mail firstname.lastname@example.org. Full product details are available on our website at https://www.mmpi.ie/investments/investment-products/